Impact of aspartate aminotransferase–to–platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma

Table 4 Selected predictor valiables for multivariable model of severe PHLF in patients with HCC

Variables	No. of risk point for severe PHLF	Odds ratio (95% CI)	P value
APRI			0.0070*
< 1.56	0	1 [Reference]
≥ 1.56	1	5.17 (2.00–13.4)
MELD score			0.0001**
< 8.3	0	1 [Reference]
≥ 8.3	1	9.11 (2.94–28.2)
Operating time (min)			< 0.0001**
< 407	0	1 [Reference]
≥ 407	1	16.8 (4.20–67.3)
Intraoperative blood loss (mL)			0.0056*
< 847	0	1 [Reference]
≥ 847	1	3.92 (1.49–10.3)

APRI AST-to-platelet ratio index, AST asparate aminotransferase, CI confidence interval, MELD model for end-stage liver disease, PHLF posthepatectomy liver failure *P < 0.05 and **P < 0.001

ISSN: 1477-7819